Adrenocortical Cancer
Adrenocortical carcinoma management depends on better understanding of molecular pathogenesis
Published in Medical Devices and Surgical Technology Week, August 13th, 2006
According to recent research published in the Journal of Clinical Endocrinology and Metabolism, "ACC is a rare and heterogeneous malignancy with incompletely understood pathogenesis and poor prognosis. Patients present with hormone excess (e.g. virilization, Cushing's syndrome) or a local mass effect (median tumor size at diagnosis >10 cm)."
"This paper reviews current diagnostic and therapeutic strategies in ACC," explained B. Allolio and colleagues, University Hospital. "Original articles...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Cardiology
Tricuspid valve replacement bileaflet mechanical valves should be implanted vertically - Primary Aldosteronism
Primary aldosteronism is associated with partially reversible renal dysfunction - Stroke
Recurrent stroke can be prevented with lower target blood pressures - Urology
Penile prosthesis surgery patient satisfaction factors are determined - Aesthetic Medicine
Lumenis launches ActiveFX procedure for skin rejuvenation - Anemia
Biopure applies for marketing authorization of Hemopure in the United Kingdom - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
